Our study reveals that serum FGF19 and ISSI-2 are lower in DM participants than in N-DM participants, which means that FGF19 may regulate islet β-cell secretion and insulin levels via the BA-FXR-FGF19 axis and GLP-1 secretion. This evidence concerns the gene INS and diabetes mellitus.